InvestorsHub Logo
Followers 68
Posts 5584
Boards Moderated 0
Alias Born 01/13/2012

Re: gabrielarch post# 41428

Monday, 07/28/2014 12:13:12 PM

Monday, July 28, 2014 12:13:12 PM

Post# of 333827
Hey Michel - I think your opinion is very well thought out. However, I offer this counter-opinion.

Let's just say that big pharma had some level of undue influence on FDA staff and management, even going to what I think is the outrageous, to the point of bribery, which is indictable.

http://www.oge.gov/Topics/Gifts-and-Payments/Bribery/

QUOTE Your personal opinion, "personally, I think big pharma is holding this down, and has some people in there pockets. can't prove it .but think how much money big pharma stand to loose with this product. and the lives it will save countless in the future.this product should be a category 1 not 2" UNQUOTE.

I counter with this personal opinion - I believe big pharma players are not stupid enough to risk their careers, years of combat with the FBI, financial and public ruin and jail by bribing or even attempting to bribe FDA staff and management. No one these days is that incredibly stupid, either in big pharma or the FDA. Call me naïve, but I happen to know for a fact that anyone with any influence at the FDA is double degreed, which indicates intelligence and work ethic. Anyone at the VP level or higher in big pharma is doing very well financially.

So, my bet is that big pharma decision makers have already got their radar on PEMF/SWT and the Proposed Order by the FDA on the sound business theory that they want to be part of the coming shift away from chemical drugs. There are a number of device manufacturers awaiting the new Class II Order by the FDA. BIEL is in a fortunate position with patented devices for general use by the public on mild and medium intermittent and chronic pain issues. So, if I'm big pharma, I stay quiet so as to avoid anyone saying big pharma had any influence on the FDA issuing it Order making such devices Class II with the opportunity for OTC. Then, when the final regulatory processes are complete, big pharma player and BIEL go public with an announcement. Nothing else makes much sense to me.